HomeCompareTMXXF vs MRK

TMXXF vs MRK: Dividend Comparison 2026

TMXXF yields 1.80% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 TMXXF wins by $40.75M in total portfolio value· pulled ahead in Year 3
10 years
TMXXF
TMXXF
● Live price
1.80%
Share price
$35.43
Annual div
$0.64
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$40.81M
Annual income
$36,867,334.85
Full TMXXF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — TMXXF vs MRK

📍 TMXXF pulled ahead of the other in Year 3

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodTMXXFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, TMXXF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
TMXXF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

TMXXF
Annual income on $10K today (after 15% tax)
$152.77/yr
After 10yr DRIP, annual income (after tax)
$31,337,234.62/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, TMXXF beats the other by $31,328,906.21/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of TMXXF + MRK for your $10,000?

TMXXF: 50%MRK: 50%
100% MRK50/50100% TMXXF
Portfolio after 10yr
$20.43M
Annual income
$18,438,566.50/yr
Blended yield
90.24%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

TMXXF
Analyst Ratings
1
Buy
Consensus: Buy
Altman Z
0.4
Piotroski
8/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

TMXXF buys
0
MRK buys
0
No recent congressional trades found for TMXXF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricTMXXFMRK
Forward yield1.80%2.76%
Annual dividend / share$0.64$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%32.7%
Portfolio after 10y$40.81M$56.8K
Annual income after 10y$36,867,334.85$9,798.13
Total dividends collected$40.48M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusBuyBuy

Year-by-year: TMXXF vs MRK ($10,000, DRIP)

YearTMXXF PortfolioTMXXF Income/yrMRK PortfolioMRK Income/yrGap
1$11,059$359.46$11,206$366.19$147.00MRK
2$12,577$743.08$12,650$502.35$73.00MRK
3← crossover$15,037$1,579.48$14,407$694.19+$630.00TMXXF
4$19,619$3,529.74$16,585$967.82+$3.0KTMXXF
5$29,600$8,608.22$19,342$1,363.89+$10.3KTMXXF
6$55,949$24,276.36$22,913$1,947.19+$33.0KTMXXF
7$145,633$85,767.56$27,662$2,823.89+$118.0KTMXXF
8$573,117$417,289.71$34,159$4,173.35+$539.0KTMXXF
9$3,682,737$3,069,502.06$43,337$6,308.80+$3.64MTMXXF
10$40,807,863$36,867,334.85$56,776$9,798.13+$40.75MTMXXF

TMXXF vs MRK: Complete Analysis 2026

TMXXFStock

TMX Group Limited operates exchanges, markets, and clearinghouses primarily for capital markets in Canada and internationally. The company operates through four segments: Global Solutions, Insights & Analytics; Capital Formation; Derivatives Trading and Clearing; and Equities and Fixed Income Trading & Clearing. The Global Solutions, Insights & Analytics segment delivers equities and index data, as well as integrated data sets for the proprietary and third party analytics to help clients in making trading and investment decisions; and provides solutions to European and global wholesale energy markets for price discovery, trade execution, post-trade transparency, and straight through processing. The Capital Formation segment operates Toronto Stock Exchange, a national stock exchange for the senior equities market; TSX Venture Exchange, a national stock exchange for the public venture equity market; and TSX Trust that provides corporate trust, registrar, transfer agency, and foreign exchange services. The Derivatives Trading & Clearing segment operates Montreal Exchange, a national derivatives exchange; Canadian Derivatives Clearing Corporation, a clearinghouse for options and futures contracts; and various over-the-counter products and fixed income repurchase agreements. The Equities and Fixed Income Trading & Clearing segment engages in the trading operations of Toronto Stock Exchange, TSX Venture Exchange, and TSX Alpha Exchange; and clearing and settlement of equities and fixed income transactions, and custody of securities; and provision of fixed income inter-dealer brokerage services. The company was formerly known as Maple Group Acquisition Corporation and changed its name to TMX Group Limited in August 2012. TMX Group Limited was incorporated in 2011 and is headquartered in Toronto, Canada.

Full TMXXF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this TMXXF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

TMXXF vs SCHDTMXXF vs JEPITMXXF vs OTMXXF vs KOTMXXF vs MAINTMXXF vs JNJTMXXF vs ABBVTMXXF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.